Christian Ruebe

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh, Jöerg Schubert, Marita Ziepert et al. · The Lancet Oncology · 2008 · 1.1K citations

Hematological Malignancy, Lymphoid Neoplasia, Elderly Patients +7

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Norbert Schmitz, Maike Nickelsen, Marita Ziepert et al. · The Lancet Oncology · 2012 · 247 citations

Hematological Malignancy, Lymphoid Neoplasia, Conventional Chemotherapy +8

Wilms' Tumor in Adults: Results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study

Harald Reinhard, S. Aliani, Christian Ruebe et al. · Journal of Clinical Oncology · 2004 · 159 citations · Full text

Phase III results of adjuvant radiotherapy (RT) versus wait-and-see (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96–02/AUO AP 09/95)

Thomas Wiegel, Dirk Bottke, Normann Willich et al. · Journal of Clinical Oncology · 2007 · 105 citations

Radiation Medicine, Surgical Oncology, Urology +14

Phase III results of adjuvant radiotherapy (RT) versus “wait and see” (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96–02/AUO AP 09/95)

Thomas Wiegel, Dirk Bottke, Normann Willich et al. · Journal of Clinical Oncology · 2005 · 80 citations